PROTHENA CORPORATION PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.16 USD | +7.18% |
|
-3.34% | -38.75% |
| 09/05 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
| 08/05 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTHENA CORPORATION PLC | Bio Therapeutic Drugs | +7.64% | -3.34% | -38.75% | -70.31% | +128.54% | 111.2Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PRTA Stock
- Charts Prothena Corporation plc
- Comparison Chart
